First National Bank of Mount Dora Trust Investment Services Sells 88 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

First National Bank of Mount Dora Trust Investment Services cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,419 shares of the healthcare conglomerate’s stock after selling 88 shares during the period. First National Bank of Mount Dora Trust Investment Services’ holdings in UnitedHealth Group were worth $4,259,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in UNH. Bristol Gate Capital Partners Inc. raised its holdings in shares of UnitedHealth Group by 7.2% in the second quarter. Bristol Gate Capital Partners Inc. now owns 184,925 shares of the healthcare conglomerate’s stock valued at $94,175,000 after purchasing an additional 12,372 shares during the last quarter. Intech Investment Management LLC increased its holdings in UnitedHealth Group by 1.0% during the second quarter. Intech Investment Management LLC now owns 337,254 shares of the healthcare conglomerate’s stock worth $171,750,000 after buying an additional 3,348 shares during the last quarter. Brighton Jones LLC increased its holdings in UnitedHealth Group by 47.4% during the second quarter. Brighton Jones LLC now owns 26,302 shares of the healthcare conglomerate’s stock worth $13,394,000 after buying an additional 8,458 shares during the last quarter. Ieq Capital LLC increased its holdings in UnitedHealth Group by 4.6% during the second quarter. Ieq Capital LLC now owns 62,584 shares of the healthcare conglomerate’s stock worth $31,872,000 after buying an additional 2,775 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. increased its holdings in UnitedHealth Group by 4.8% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 39,031 shares of the healthcare conglomerate’s stock worth $19,877,000 after buying an additional 1,770 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 0.1 %

Shares of NYSE UNH opened at $510.03 on Friday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $469.37 billion, a price-to-earnings ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a 50-day moving average price of $551.50 and a two-hundred day moving average price of $562.62.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.83 earnings per share. As a group, analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. TD Cowen upped their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a report on Friday. Finally, Barclays decreased their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday. Two analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.